Yi H. Wong
Singapore, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Host-directed therapy for tuberculosis: Repurposed drugs toward global tuberculosis elimination.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: January 22, 2026
Mutagenesis-Guided Target Identification Reveals the Protein-Binding Domain of Nsp14 in Coronaviruses as the Target of a Labdane-Oxindole Compound.
Journal: ACS infectious diseases
Published: April 10, 2025
MMPs and NETs are detrimental in CNS-tuberculosis with MMP Inhibition in CNS-tuberculosis mice improving survival.
Journal: Journal of neuroinflammation
Published: February 14, 2025
A conserved long-range RNA interaction in SARS-CoV-2 recruits ADAR1 to enhance virus proliferation.
Journal: Nature communications
Published: December 13, 2024
Immune dysregulation of diabetes in tuberculosis.
Journal: Seminars in immunology
Published: November 13, 2024
Attenuation of neurovirulence of chikungunya virus by a single amino acid mutation in viral E2 envelope protein.
Journal: Journal of biomedical science
Published: September 28, 2023
CUR-N399, a PI4KB inhibitor, for the treatment of Enterovirus A71 infection.
Journal: Antiviral research
Published: July 08, 2023
The Current Progress in the Quest for Vaccines Against the Semliki Forest Virus Complex.
Journal: Medicinal research reviews
Published: May 26, 2023
AAV-CRISPR-Cas13 eliminates human enterovirus and prevents death of infected mice.
Journal: EBioMedicine
Published: February 15, 2023
Evaluation of In Vitro and In Vivo Antiviral Activities of Vitamin D for SARS-CoV-2 and Variants.
Journal: Pharmaceutics
Published: December 12, 2022
The host-targeting compound peruvoside has a broad-spectrum antiviral activity against positive-sense RNA viruses.
Journal: Acta pharmaceutica Sinica. B
Published: October 31, 2022
Last Updated: 09/26/2026